174 results
8-K
EX-1.1
CRNX
Crinetics Pharmaceuticals Inc
21 Jun 24
Other Events
5:24pm
or through any building or structure.
(gg) Compliance with ERISA. (i) Each employee benefit plan, within the meaning of Section 3(3) of the Employee … director, officer, or employee of the Company or any of its subsidiaries nor, to the knowledge of the Company, any agent, affiliate or other person
S-3ASR
CRNX
Crinetics Pharmaceuticals Inc
21 Jun 24
Automatic shelf registration
4:45pm
and also officers and (b) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether … , employee or agent of the corporation, or a person serving at the request of the corporation for another corporation, partnership, joint venture, trust
8-K
EX-99.3
CRNX
Crinetics Pharmaceuticals Inc
3 Jun 24
Regulation FD Disclosure
4:35pm
employee productivity; our dependence on third parties in connection with product manufacturing, research and preclinical and clinical testing
8-K
EX-99.1
9t2h8 2wl9yfj
9 May 24
Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results
4:12pm
8-K
8f4py
4 Apr 24
Departure of Directors or Certain Officers
4:52pm
S-3ASR
pdq 465se7
19 Mar 24
Automatic shelf registration
4:05pm
8-K
EX-99.2
xv201f
19 Mar 24
Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-2 Study in Acromegaly Patients
6:31am
8-K
EX-99.2
vd768xsep4qnlt
12 Mar 24
Crinetics Announces Positive Topline Results from Phase 2 Trial of Paltusotine for the Treatment of Carcinoid Syndrome
4:25pm
S-8 POS
l059 re2c
1 Mar 24
Registration of securities for employees (post-effective amendment)
4:41pm
8-K
EX-10.1
brgz8llo6gpijapp6e
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
S-8
EX-5.1
j4ghlomngf0zaf
28 Feb 24
Registration of securities for employees
6:04pm
S-8
usnc7 kyevspy
28 Feb 24
Registration of securities for employees
6:04pm
S-8
vlltnof
28 Feb 24
Registration of securities for employees
6:04pm
8-K
EX-99.1
86you3vzmfxlw
28 Feb 24
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
4:09pm
8-K
EX-99.1
86taa
8 Jan 24
Regulation FD Disclosure
8:03am